Sumitomo Chemical India Ltd (SUMICHEM) — shareholding pattern, promoter holding, financials and share price
About Sumitomo Chemical India Ltd (SUMICHEM)
Sumitomo Chemical India Ltd operates in the Pesticides & Agrochemicals industry, within the Chemicals sector. It trades on the NSE as SUMICHEM and on the BSE under scrip code 542920. Its ISIN is INE258G01013.
Sumitomo Chemical India Ltd. (SCIL) is one of the leading players in the industry which has a balanced portfolio of technical as well as formulation products along with backward integration for some products. The Company is known for domestic marketing of proprietary products of its Japanese parent -Sumitomo Chemical Company Limited in agrochemicals, animal nutrition, and environmental health business segments. With the integration of Excel Crop Care Limited, the Company now has a strong portfolio of generics in addition to specialty products and a strong combined marketing network. With this integration, the Company has moved up several notches in the pecking order of the Indian crop protection industry. SCIL has also marked its presence in Africa and several other geographies of the world. [1] [2]
Sumitomo Chemical India Limited (SCIL) operates in the agrochemical sector, focusing on manufacturing and distributing household insecticides, agricultural pesticides, and animal nutrition products. "Sumitomo Chemical India Limited experienced a decline in Q3FY26 revenue by 12% year-over-year due to various factors, including the discontinuation of the Animal Nutrition products distribution in India.
Despite revenue declines, SCIL saw a gross margin expansion to 47.4% in Q3FY26, due to a favorable product mix and cost discipline.
Listed peers in Pesticides & Agrochemicals: P I Industries Ltd, Bayer CropScience Ltd, Sharda Cropchem Ltd, NACL Industries Ltd, Dhanuka Agritech Ltd, Rallis India Ltd.
Valuation & Returns
10 Jul 2026At ₹513.6 a share on 10 Jul 2026, Sumitomo Chemical India Ltd (SUMICHEM) was valued at a price-to-earnings ratio of 47.21x against an industry P/E of 22.12x and a price-to-book of 7.56x on a book value of ₹67.91 per share as of Mar 2026. Solomo computes return on equity of 16.02% and return on capital employed of 21.3% from filed results. Earnings ratios use consolidated results for the twelve months Jun 2025 to Mar 2026.
- P/E
- 47.21x
- Industry P/E
- 22.12x
- P/B
- 7.56x
- EPS (TTM)
- ₹10.88
- Book value / share
- ₹67.91
- ROE
- 16.02%
- ROCE
- 21.3%
- ROA
- 12.14%
- Debt / equity
- 0.02x
- Dividend yield
- 0.23%
- EBITDA margin
- 24.75%
- 52-week range
- ₹363.3 – ₹665
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Sumitomo Chemical India Ltd (SUMICHEM) reported revenue of ₹3,238 crore, net profit of ₹543 crore and earnings per share of ₹10.88. That compares with revenue of ₹3,149 crore and net profit of ₹506 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹684 crore and net profit ₹111 crore (consolidated).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 3,061 | 3,511 | 2,844 | 3,149 | 3,238 |
| Net profit (₹ cr) | 424 | 502 | 370 | 506 | 543 |
| EPS (₹) | 8.49 | 10.06 | 7.4 | 10.13 | 10.88 |
| Measure | 10Y | 5Y | 3Y | 1Y |
|---|---|---|---|---|
| Sales growth | 15.06% | 3.81% | -3.19% | 2.85% |
| Profit growth | 27.36% | 9.48% | 2.56% | 7.22% |
| Stock price CAGR | - | 4% | 8% | -8% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 75% of Sumitomo Chemical India Ltd (SUMICHEM) (unchanged from the previous quarter), foreign institutional investors (FII) hold 3.02% and domestic institutional investors (DII) hold 9.33%. Market capitalisation was ₹25,636 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2020.
Largest disclosed public shareholders in Jun 2026: Aditya Birla Sun Life Trustee Private Limited A/C Aditya Birla Sun Life Flexi Cap Fund 2.28%, Edelweiss Trusteeship Co Ltd Ac- Edelweiss Mf Ac- Edelweiss Mid Cap Fund 1.24%, Hsbc Mutual Fund - Hsbc Small Cap Fund 1.09%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 75% | - | 3.02% | 9.33% | 25% |
| Mar 2026 | 75% | - | 3.4% | 8.98% | 25% |
| Dec 2025 | 75% | - | 3.37% | 8.65% | 25% |
| Sep 2025 | 75% | - | 3.65% | 8.47% | 25% |
| Jun 2025 | 75% | - | 3.65% | 8.15% | 25% |
| Mar 2025 | 75% | - | 3.63% | 8.14% | 25% |
| Dec 2024 | 75% | - | 3.59% | 6.96% | 25% |
| Sep 2024 | 75% | - | 3.49% | 6.97% | 25% |